BACKGROUND: A unique schedule of 7-valent pneumococcal conjugate vaccine (7PCV) at 2, 4 and 6 months of age and 23-valent pneumococcal polysaccharide vaccine (23PPV) at 18 months commenced for Australian Aboriginal infants in 2001. METHODS: Anti-capsular IgG concentrations in vaccinated and non-vaccinated (historic control) infants were determined (blinded) by (22F absorbed) ELISA. RESULTS: One month after dose 3 of 7PCV, geometric mean concentrations (GMCs) were >1.95 microg/ml and at least 89% of infants had IgG >0.35 microg/ml to all 7PCV serotypes. One month post-23PPV, IgG to 7PCV serotypes was >0.35 microg/ml for more than 96% infants (>1.3 microg/ml for at least 70%), and IgG to non-7PCV serotypes was >0.35 microg/ml for more than 50% infants (including serotype 6A, but not 12F (17%) or 19A (44%). CONCLUSION: 7PCV and 23PPV are immunogenic in this population.
BACKGROUND: A unique schedule of 7-valent pneumococcal conjugate vaccine (7PCV) at 2, 4 and 6 months of age and 23-valent pneumococcal polysaccharide vaccine (23PPV) at 18 months commenced for Australian Aboriginal infants in 2001. METHODS: Anti-capsular IgG concentrations in vaccinated and non-vaccinated (historic control) infants were determined (blinded) by (22F absorbed) ELISA. RESULTS: One month after dose 3 of 7PCV, geometric mean concentrations (GMCs) were >1.95 microg/ml and at least 89% of infants had IgG >0.35 microg/ml to all 7PCV serotypes. One month post-23PPV, IgG to 7PCV serotypes was >0.35 microg/ml for more than 96% infants (>1.3 microg/ml for at least 70%), and IgG to non-7PCV serotypes was >0.35 microg/ml for more than 50% infants (including serotype 6A, but not 12F (17%) or 19A (44%). CONCLUSION: 7PCV and 23PPV are immunogenic in this population.
Authors: Paul V Licciardi; Anne Balloch; Fiona M Russell; Robert L Burton; Jisheng Lin; Moon H Nahm; Edward K Mulholland; Mimi L K Tang Journal: J Allergy Clin Immunol Date: 2012-02-02 Impact factor: 10.793
Authors: Amanda Jane Leach; Edward Kim Mulholland; Mathu Santosham; Paul John Torzillo; Ngiare Joy Brown; Peter McIntyre; Heidi Smith-Vaughan; Sue Skull; Anne Balloch; Ross Andrews; Jonathan Carapetis; Joseph McDonnell; Vicki Krause; Peter Stanley Morris Journal: BMJ Open Date: 2015-01-16 Impact factor: 2.692
Authors: Jemima Beissbarth; Heidi C Smith-Vaughan; Allen C Cheng; Peter S Morris; Amanda J Leach Journal: Front Pediatr Date: 2022-04-14 Impact factor: 3.418
Authors: Amanda J Leach; Peter S Morris; Gabrielle B McCallum; Cate A Wilson; Liz Stubbs; Jemima Beissbarth; Susan Jacups; Kim Hare; Heidi C Smith-Vaughan Journal: BMC Infect Dis Date: 2009-08-04 Impact factor: 3.090
Authors: Grant Austin Mackenzie; Jonathan Rhys Carapetis; Amanda Jane Leach; Peter Stanley Morris Journal: BMC Pediatr Date: 2009-02-19 Impact factor: 2.125